Superstring Capital Management LP Spruce Biosciences, Inc. Transaction History

Superstring Capital Management LP

  • $114 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.51 - $0.85 $184,738 - $307,898
-362,233 Reduced 82.28%
77,992 $40.4 Million
Q1 2024

May 15, 2024
BUY
$0.7 - $5.49 $224,987 - $1.76 Million
321,411 Added 270.52%
440,225 $346 Million
Q4 2023

Feb 14, 2024
BUY
$1.04 - $2.93 $123,566 - $348,125
118,814 New
118,814 $348 Million

Others Institutions Holding SPRB

# of Institutions
34
Shares Held
15.4M
Call Options Held
16.7K
Put Options Held
1.1K
View Full List

About SPRUCE BIOSCIENCES, INC.

SPRB Quotes by TradingView
  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $9.42M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email